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Edited by Richard MaraisAbstract To investigate the importance of protein kinase D
(PKD) enzymes we generated a PKD-null DT40 B-lymphocyte
cell line. Previously we have shown that PKDs have an essential
role in regulating class II histone deacetylases in DT40 B-cells
[Matthews, S.A., Liu, P., Spitaler, M., Olson, E.N., McKinsey,
T.A., Cantrell, D.A. and Scharenberg, A.M. (2006) Essential
role for protein kinase D family kinases in the regulation of class
II histone deacetylases in B lymphocytes. Mol. Cell Biol. 26,
1569–1577]. We now show that PKDs are also required to regu-
late HSP27 phosphorylation in DT40 B-cells. However, in con-
trast to previous observations in other cell types, PKD enzymes
do not regulate basic cellular processes such as proliferation or
survival responses, nor NFjB transcriptional activity down-
stream of the B cell antigen receptor. Thus, PKDs have a selec-
tive role in DT40 B-cell biology.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V.
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The protein kinase D (PKD) serine/threonine kinase family
has three members: PKD1, PKD2 and PKD3. Most cell types
express at least two PKD isoforms but PKD enzymes are espe-
cially highly expressed in haematopoietic cells, where they are
activated in response to antigen receptors stimulation [2,3]. A
conserved signalling pathway linking antigen receptors to
PKDs involves the activation of PLCc and the subsequent pro-
duction of diacylglycerol (DAG) which stimulates classical
and/or novel protein kinase Cs (PKC) that phosphorylate
two key regulatory serine residues in the activation loop of
PKD kinases [3–6]. The N-terminal regulatory region of
PKD enzymes contains a DAG binding domain and direct
binding of DAG also contributes to PKD1 activation [7] as
well as regulating the spatial location of PKD enzymes within
cells [8–12].Abbreviations: PKD, protein kinase D; PKC, protein kinase C; BCR,
B cell antigen receptor
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doi:10.1016/j.febslet.2007.02.055PKD enzymes have been proposed to regulate numerous
cellular functions, including cell proliferation [13–16], anti-
apoptotic signals [17,18] and thymocyte development [19].
Expression of mutant catalytically inactive and constitutively
activated PKDs can also modify Golgi function, cell adhesion
and cell motility (reviewed in [20]). In particular, PKDs have
been widely linked to the activation of the NFjB transcription
factor and in regulating cell survival during oxidative stress
[17,21–23]. Another recently proposed PKD1 substrate is
HSP27 [24], a small heat shock protein involved in regulating
cell migration and cell survival [25]. An essential role for PKD
enzymes in regulating class II histone deacetylases (HDACs),
enzymes that repress MEF2-dependent gene transcription,
has also been demonstrated [1,26–28].
To investigate the biological role of PKDs we have gener-
ated DT40 B cell lines that lack expression of one or more
members of the PKD family [1], allowing us to investigate
the function(s) of PKD isoforms following B cell antigen
receptor (BCR) stimulation, as well addressing the issue of
functional redundancy between the diﬀerent PKD family
members. Previous studies have shown that PKDs are indis-
pensable for HDAC regulation in B cells [1]. Herein we show
that PKDs are also indispensable for HSP27 phosphorylation
in B cells. However, PKD-null DT40 B cells are viable and
proliferate normally. Moreover, loss of the entire cellular pool
of PKD does not critically aﬀect oxidative stress responses in B
cells nor do PKD kinases play an essential role in regulating
NFjB transcriptional activity. Together, these ﬁndings reveal
that in B lymphocytes, PKD kinases are not critical regulators
of many of the cellular processes previously ascribed to them in
other cellular systems.2. Materials and methods
2.1. Cell culture, transient transfections and cell stimulation
The generation, culture and activation of PKD1/, PKD3/ and
PKD1/3/ knockout DT40 B cell lines have been described previously
[1]. Cells were lysed and protein extracts were analysed in Western
blotting experiments as previously described [1]. Chloramphenicol
acetyl transferase assays have been described previously [29].
2.2. sIgM staining
DT40 B cells (2 · 106 cells per point) were resuspended in 200 ll buf-
fer (RPMI 1640 media, 1% foetal calf serum) containing anti-chicken
M1 monoclonal antibody conjugated to FITC for 20 min on ice. The
cells were washed twice and ﬂuorescent intensity was analysed by ﬂow
cytometry.
All results shown are representative of at two to four independent
experiments unless otherwise indicated.by Elsevier B.V. Open access under CC BY license.
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3.1. Loss of HSP27 phosphorylation in DT40 B cells lacking
expression of PKD family kinases
DT40 B cells express two PKD isoforms, PKD1 and PKD3,
and as previously described we have recently generated DT40
B cell lines that lack expression of either PKD1 or PKD3 or
both enzymes [1]. In generating the double knockout cell
lines we targeted the PKD1 loci in a PKD3/ cell line that
expressed a Flag-PKD3 transgene under the control of a
doxycycline-inducible promoter. Hence, in the presence of
doxycycline, Flag-PKD3 expression in PKD1/3 double knock-
out cells is comparable to endogenous PKD3 present in wild-
type DT40 cells and removal of doxycycline from the culture
media for 5 days results in a completely null PKD phenotype
(Fig. 1A).
Previously, we have demonstrated that phosphorylation and
nuclear exclusion of class II histone deacetylases (HDACs)
during BCR engagement is defective in PKD1/3/ B cells
and can restored upon re-expression of a single PKD isoform
[1]. The small heat shock protein HSP27 has recently been pro-
posed as a PKD1 substrate [24] and we accordingly assessed
whether PKD-null DT40 cells have defective phosphorylation
of HSP27 on serine 82, the proposed PKD1 substrate se-
quence. We initially investigated the regulation of HSP27
phosphorylation in single knockout DT40 B cells lacking
either PKD1 or PKD3. As shown in Fig. 1B, activation of
the BCR or treatment with the DAG-mimetic PdBu increased
the levels of HSP27 phosphorylation at S82 in wild-type DT40
B cells. BCR and phorbol ester signals were also able to in-Fig. 1. (A) Expression and activation of PKD enzymes in wild-type and PKD
and analyzed by Western blotting of whole cell extracts with the indicated an
in doxycycline (to maintain Flag-PKD3 expression) or were washed out of do
phosphorylation in PKD1/3/ DT40 B cells. Wild-type, PKD1/, PKD3/
HSP27 expression construct. In Fig. 1D, PKD1/3/ DT40 B cells were co
or GFP-PKD3 K605 N constructs, as indicated. The cells were then left unt
PdBu( P) for 30 min. Flag immunoprecipitates were analysed by SDS–PAGcrease HSP27 phosphorylation in PKD1 or PKD3 single
knockout DT40 B cells (Fig. 1B). However, BCR- and phorbol
ester-induced phosphorylation of HSP27 on S82 was abolished
in B cells that lacked both PKD1 and PKD3 (Fig. 1C). Signif-
icantly, doxycycline-induced expression of the Flag-PKD3
transgene in the double knockout cells was suﬃcient to restore
normal regulation of HSP27 phosphorylation (Fig. 1C). In
contrast, expression of a kinase-deﬁcient PKD3 mutant pro-
tein in the double knockout cells was not able to restore
BCR- or phorbol ester-induced HSP27 phosphorylation
(Fig. 1D). Hence, PKD3 as well as PKD1 can regulate
HSP27 phosphorylation and in DT40 B cells they are function-
ally redundant as HSP27 kinases.
3.2. Cellular proliferation and survival in DT40 B cells lacking
expression of PKD family kinases
PKD enzymes have previously been linked to the regulation
of cell proliferation and survival (reviewed in [20]). To investi-
gate the eﬀect that loss of PKD kinases had on B cell survival
and/or proliferation we cultured wild-type and PKD-null cells
in the presence (PKD1/3/: Flag-PKD3+ve) or absence
(PKD1/3/) of doxycycline and monitored exponential
growth. As shown in Fig. 2A, PKD1/3/ cells proliferated
exponentially and re-expression of Flag-PKD3 in these cells
had no impact on the rate of proliferation. Furthermore, the
viability of PKD1/3/ B cells during routine culturing was
not signiﬁcantly diﬀerent from that of wild-type B cells (data
not shown). It was noted that the population doubling time
of PKD1/3/ cells was slightly slower than that of wild type
DT40 cells (12.7 ± 2.8 h versus 10.2 ± 0.4 h) but the failure1/3/DT40 B cells. Cells were treated ± = 25 ng/ml PdBu for 10 min
tibodies. PKD1/3/DT40 B cells were either continuously maintained
xycycline for 5 days (to generate a PKD-null phenotype). (B–D) HSP27
and PKD1/3/ DT40 B cells were transiently transfected with a Flag-
-transfected with Flag-HSP27 and either GFP, GFP-PKD3 wild-type
reated or were stimulated with either 10 lg/ml M 4(BCR) or 25 ng/ml
E and Western blotting the indicated antibodies. * = IgL chain.
Fig. 2. Growth and cell survival responses in PKD1/3/ DT40 B cells. (A) Exponentially growing wild-type, PKD1/3//PKD3+ and PKD1/3/
(washed out of doxycycline for at least 5 days) DT40 B cells were plated at a cell density of 1 · 104/ml and cell number was counted daily. Results
shown are the mean ± S.E. of triplicate cultures and are representative of two to three independent experiments. (B) Wild-type and PKD1/3/ DT40
B cells were cultured at a density of 1 · 105 cells/ml with increasing concentrations of the indicated stimuli. After 24–48 h in culture, the number of
viable cells in the cultures was determined by ﬂow cytometry, using CalBRITE (Becton Dickinson) beads for quantitation of cell numbers. The data
are expressed as a percentage of the number of viable cells present in control, non-treated cultures for each cell line (untreated = 100%). In some
cases, the data are presented as the % cell death after 24 h as determined by ﬂow cytometry, gating on 7AAD+ cells. All results are representative of at
least two to four independent experiments. TSA, Trichostatin A.
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PKD1/3/ cells suggests that these small diﬀerences were
most likely the result of clonal variation and were not caused
speciﬁcally by loss of PKD enzymes. Thus, PKD family en-
zymes are not essential for regulating basal survival and prolif-
eration of DT40 B cells.
PKD enzymes, speciﬁcally PKD1 and PKD2, have previ-
ously been linked to a protective role against oxidative
stress-induced injury in 3T3 ﬁbroblast, HeLa and epithelial cell
lines [17,30–32]. We therefore addressed the role of PKD fam-
ily kinases in regulating B cell survival in response to oxidative
stress and other stress stimuli. As shown in Fig. 2B, loss of
PKD1/3 expression had no signiﬁcant impact on the survival
of DT40 B cells in response to mitochondrial stress stimuli
(H2O2 or serum deprivation); DNA damaging agents (etopo-
side or doxorubicin); ER pathway stress due to calcium over-
load (thapsigargin) or following prolonged treatment with
phorbol esters or Trichostatin A, an inhibitor of class I/II
HDACs. Thus, PKD kinases do not play an essential role in
regulating B cell survival in response to a range of diﬀerent
stress stimuli.
3.3. Antigen receptor regulated signalling pathways in PKD-null
DT40 B cells
To further explore the contribution of PKD kinases to DT40
B cell biology we investigated whether speciﬁc BCR-regulated
signalling events were defective in the PKD-null B cells. Initial
experiments revealed that surface expression of the BCR was
reduced in PKD1/3/ (and in PKD1/3/:Flag-PKD3+ve)
cells compared to wild-type DT40 B cells (Fig. 3A and data
not shown). Nevertheless, BCR-crosslinking of PKD1/3/
cells was suﬃcient to induce the activation of a number of sig-
nalling cascades, similar to that observed in wild-type cells
(Fig. 3B). Hence, BCR-induced activation of the Akt,
mTOR/p70 S6 kinase (as shown by S6 ribosomal protein phos-
phorylation) and MAPK signalling pathways was clearly
detectable in PKD1/3-null B cells (Fig. 3B). Furthermore, en-hanced tyrosine phosphorylation of multiple cellular proteins
as well as an increase in intracellular calcium levels was also
observed following BCR stimulation of PKD1/3-null B cells
(data not shown). We did observe that the strength of BCR
(but not phorbol ester)-induced regulation of the Erk1-RSK1
signalling pathway was reduced in PKD1/3/ B cells com-
pared to wild-type B cells (Fig. 3B). One interpretation of this
data is that PKD enzymes may modulate Erk activation. In-
deed, PKD enzymes have previously been linked to the growth
factor-regulated Erk signalling in ﬁbroblast and endothelial
cell lines [33–35]. However, BCR-induced Erk phosphoryla-
tion was also reduced in PKD1/3/-Flag-PKD3+ B cells (data
not shown) suggesting that reduced BCR levels on the surface
of PKD1/3/ (and PKD1/3/-Flag-PKD3+) B cells may it-
self impact on the strength of activation of this speciﬁc intra-
cellular signalling pathway.
To search for other potential PKD targets that may show
defective regulation in PKD1/3/ DT40 B cells, we used a
PKD substrate phospho-antibody that recognises consensus
phosphorylation sequences targeted by PKD enzymes
(LxRxxpS/T) [36]. As shown in Fig. 3C, phorbol ester- and
BCR-induced phosphorylation of cellular substrates detected
by this phospho-antibody was similar in wild-type and
PKD1/3/ cells and is therefore independent of PKD en-
zymes. However, pretreatment of both wild-type and PKD1/
3/ DT40 B cells with GF109203X, a bisindoylmaleimide
derivative that inhibits PKCs prevented the induction of pro-
teins that contain phosphorylated LxRxxS/T motifs. Thus loss
of PKD1/3 enzymes does not globally disrupt the phosphory-
lation of cellular proteins that contain LxRxxpS/T motifs. This
result is perhaps not surprising as LxRxxS/T motifs also act as
good substrates for other serine/threonine kinases such as
MAPKAPK2. However these experiments do provide further
evidence that phosphospeciﬁc antisera are not suﬃciently
selective to be designated kinase speciﬁc substrate antisera.
BCR-induced signalling pathways culminate in the activa-
tion of gene transcription events that control B cell survival,
Fig. 3. BCR-induced signalling events in PKD1/3/ DT40 B cells. (A) Flow cytometric analysis of surface BCR expression (as detected by IgM
levels) in wild-type, PKD1/3//PKD3+ and PKD1/3/DT40 cells. (B) Wild-type and PKD1/3/DT40 cells were cultured in 0.5% FBS-containing
media for 6 h, then with or without 10 lg/ml M4 (BCR) or 25 ng/ml PdBu (P) for the indicated times and cellular extracts were analysed by SDS–
PAGE and Western blotting with the indicated antibodies. (C) Wild-type and PKD1/3/DT40 cells, pretreated for 1 h with 5 lMGF109203X (GF)
or DMSO solvent () were stimulated with or without 25 ng/ml PdBu (P) or 10 lg/ml M4 (BCR) for 30 min before cellular extracts were analysed by
SDS–PAGE and Western blotting with a phospho-LxRxxpS/T motif antibody (CST, #4381).
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posed that PKD family members control of gene transcription
through activation of the NFjB transcription factor. Thus,
PKD-mediated activation of NFjB occurs downstream
of a variety of diﬀerent signals, including mROS/oxidative
stress, lysophosphatidic acid and the Bcr-Abl oncogene
[17,21,23,30,37]. Furthermore, expression of an activated
PKD1 mutant enhances HPK1-mediated NFjB activation
[38]. In B cells, NFjB is known to be regulated via DAG
and PKCb [39,40] but whether PKDs are key intermediaries
for NFjB regulation has not been explored.
The data (Fig. 4A) show that NFjB transcriptional activity
was strongly induced in both wild-type and PKD1/3/ DT40
B cells in response to either phorbol ester or BCR stimulation.In contrast, BCR and phorbol ester-induced NFjB transcrip-
tional activity was abolished in PKCb/ DT40 B cells
(Fig. 4A), although strong activation of PKD kinases (as as-
sessed by autophosphorylation of PKD1 at S916) was ob-
served in the PKCb/ cells (Fig. 4B). Thus, PKD kinases
are neither essential nor suﬃcient to mediate BCR-induced
NFjB activation in DT40 B cells and hence do not participate
in DAG/PKC mediated control of NFjB.4. Discussion
Protein kinase D serine kinases have been proposed to reg-
ulate diverse cellular functions including the phosphorylation
Fig. 4. NFjB transcriptional activity in PKD1/3/ DT40 B cells. (A)
The indicated DT40 B cell lines were transiently transfected with an
NFjB-CAT reporter construct. The cells were then left untreated or
were stimulated with either 10 lg/ml M4 (B) or 25 ng/ml PdBu (P) for
6 h before the activity of the reporter construct was analysed as
described in Section 2. (B) Expression and activation of PKD enzymes
in wild-type, PKD1/3/ and PKCb/ DT40 B cells was performed as
described in Fig. 1A.
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ylation of HSP27. It has also been suggested that PKDs act as
mitochondrial sensors for oxidative stress and play a role in
regulating NFjB transcription factors [41]. Most of the data
about the function of PKDs has come from experiments that
ectopically express active or inhibitory PKD mutants or that
use RNAi to reduce PKD expression. We have used gene tar-
geting to speciﬁcally delete PKD alleles in DT40 chicken B
cells and can thus use PKD-null DT40 cells to assess the rela-
tive contribution of individual PKD isoforms in class II
HDAC control versus oxidative stress responses and NFjB
regulation in lymphocytes. We have previously used these
PKD-null DT40 cells to deﬁne an essential role for PKDs in
regulation of class II HDACs, the present report now describes
an indispensable role for PKDs in regulating the phosphoryla-
tion of HSP27 on serine 82, a site previously identiﬁed as a tar-
get for the p38-MAPKAPK2 signalling cascade [42]. However,
studies of PKD-null DT40 cells reveal that PKD family ki-
nases are not essential for oxidative stress survival responses
nor are they required for activation of NFjB transcription fac-
tors. These latter ﬁndings are in striking contrast to previous
observations in HeLa and epithelial cell lines where overex-
pression/RNAi approaches have implicated PKD1/2 in the
control of proliferation, survival and NFjB activation
[20,23]. Hence, the present report shows that the proposed
roles for PKDs as key sensors that modulate survival pathways
in response to oxidative stress and regulate cell survival and
proliferation are not ubiquitous and may be restricted to cer-
tain cell lineages. Taken together, these data indicate that loss
of expression of PKD family members does not globally im-
pact on early BCR-regulated signalling pathways.Acknowledgements: We thank Prof. T. Kurosaki for generously pro-
viding the PKCb/ DT40 cell line, Prof. A. Toker for the Flag-
HSP27 expression construct and Petra Volna for technical assistance.
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